Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids

Detalhes bibliográficos
Autor(a) principal: Baréa, Paula
Data de Publicação: 2022
Outros Autores: Barbosa, Valéria Aquilino, Yamazaki, Diego Alberto dos Santos, Gomes, Carla Maria Beraldi, Novello, Claudio R., da Costa, Willian Ferreira, Gauze, Gisele de Freitas, Sarragiotto, Maria Helena
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/204547
Resumo: The β-carboline-1,3,5-triazine hydrochlorides 8-13 were evaluated in vitro against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The analysed compounds were selective to BuChE, with IC50 values in the range from 1.0-18.8 µM being obtained. The N-{2-[(4,6-dihydrazinyl-1,3,5-triazin-2-yl)amino]ethyl}-1-phenyl-β-carboline-3-carboxamide (12) was the most potent compound and kinetic studies indicate that it acts as a competitive inhibitor of BuChE. Molecular docking studies show that 12 strongly interacts with the residues of His438 (residue of the catalytic triad) and Trp82 (residue of catalytic anionic site), confirming that this compound competes with the same binding site of the butyrylthiocholine.
id USP-31_b7919ba38c9f7703140c56e371ddd3b3
oai_identifier_str oai:revistas.usp.br:article/204547
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Anticholinesterase activity of β-carboline-1,3,5-triazine hybridsβ-carboline1,3,5-triazineAcetylcholinesteraseButyrylcholinesteraseThe β-carboline-1,3,5-triazine hydrochlorides 8-13 were evaluated in vitro against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The analysed compounds were selective to BuChE, with IC50 values in the range from 1.0-18.8 µM being obtained. The N-{2-[(4,6-dihydrazinyl-1,3,5-triazin-2-yl)amino]ethyl}-1-phenyl-β-carboline-3-carboxamide (12) was the most potent compound and kinetic studies indicate that it acts as a competitive inhibitor of BuChE. Molecular docking studies show that 12 strongly interacts with the residues of His438 (residue of the catalytic triad) and Trp82 (residue of catalytic anionic site), confirming that this compound competes with the same binding site of the butyrylthiocholine.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-11-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20454710.1590/s2175-97902022e19958Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/204547/194769Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBaréa, PaulaBarbosa, Valéria AquilinoYamazaki, Diego Alberto dos SantosGomes, Carla Maria BeraldiNovello, Claudio R.da Costa, Willian FerreiraGauze, Gisele de FreitasSarragiotto, Maria Helena2023-06-05T12:44:56Zoai:revistas.usp.br:article/204547Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-06-05T12:44:56Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids
title Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids
spellingShingle Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids
Baréa, Paula
β-carboline
1,3,5-triazine
Acetylcholinesterase
Butyrylcholinesterase
title_short Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids
title_full Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids
title_fullStr Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids
title_full_unstemmed Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids
title_sort Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids
author Baréa, Paula
author_facet Baréa, Paula
Barbosa, Valéria Aquilino
Yamazaki, Diego Alberto dos Santos
Gomes, Carla Maria Beraldi
Novello, Claudio R.
da Costa, Willian Ferreira
Gauze, Gisele de Freitas
Sarragiotto, Maria Helena
author_role author
author2 Barbosa, Valéria Aquilino
Yamazaki, Diego Alberto dos Santos
Gomes, Carla Maria Beraldi
Novello, Claudio R.
da Costa, Willian Ferreira
Gauze, Gisele de Freitas
Sarragiotto, Maria Helena
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Baréa, Paula
Barbosa, Valéria Aquilino
Yamazaki, Diego Alberto dos Santos
Gomes, Carla Maria Beraldi
Novello, Claudio R.
da Costa, Willian Ferreira
Gauze, Gisele de Freitas
Sarragiotto, Maria Helena
dc.subject.por.fl_str_mv β-carboline
1,3,5-triazine
Acetylcholinesterase
Butyrylcholinesterase
topic β-carboline
1,3,5-triazine
Acetylcholinesterase
Butyrylcholinesterase
description The β-carboline-1,3,5-triazine hydrochlorides 8-13 were evaluated in vitro against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The analysed compounds were selective to BuChE, with IC50 values in the range from 1.0-18.8 µM being obtained. The N-{2-[(4,6-dihydrazinyl-1,3,5-triazin-2-yl)amino]ethyl}-1-phenyl-β-carboline-3-carboxamide (12) was the most potent compound and kinetic studies indicate that it acts as a competitive inhibitor of BuChE. Molecular docking studies show that 12 strongly interacts with the residues of His438 (residue of the catalytic triad) and Trp82 (residue of catalytic anionic site), confirming that this compound competes with the same binding site of the butyrylthiocholine.
publishDate 2022
dc.date.none.fl_str_mv 2022-11-23
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/204547
10.1590/s2175-97902022e19958
url https://www.revistas.usp.br/bjps/article/view/204547
identifier_str_mv 10.1590/s2175-97902022e19958
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/204547/194769
dc.rights.driver.fl_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222916091052032